StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

TXGBullishAnalyst Target Updateanalyst
High materiality7/10

10x Genomics price target raised to $65 from $50 at Stephens

Aug 12, 2026, 5:01 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

bullish

AI summary

What happened, with direct paths to the underlying reporting

Stephens raises TXG PT to $65; current price $58.34.

  • PT $65; price $58.34; Stephens

Key facts

  1. 01

    Target: $65

  2. 02

    Posted price: $58.34

  3. 03

    Analyst firm: Stephens

  4. 04

    Analyst: Mason Carrico

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.